Myelofibrosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Historical Perspective== | ==Historical Perspective== | ||
*Gustav Heuck, a German surgeon, was the first to describe the notion of myelofibrosis in 1879. | *Gustav Heuck, a German surgeon, was the first to describe the notion of myelofibrosis in 1879. He explained the idea under the title of 'Two cases of leukemia with peculiar blood and bone marrow findings'. Heuck described two patients with massive splenomegaly, increased number of morphologically abnormal leukocytes, and nucleated red blood cells. He observed that the clinical findings in these two patients were different from those described for chronic myelogenous leukemia (CML) because of the presence of marrow fibrosis and extensive extramedullary hematopoiesis (EMH). He also noted osteosclerosis in an autopsy report.<ref>{{cite book | last = Ansell | first = Stephen | title = Rare hematological malignancies | publisher = Springer | location = New York, NY London | year = 2008 | isbn = 9780387737430 }}</ref> | ||
<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | *In 1904, Max Askanazy, a German pathologist, reported a case with significant extramedullary hematopoiesis of the liver and diffuse bone marrow fibrosis.<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | ||
* | *In 1907, Herbert Assmann, an internist from Germany, described another case of extramedullary hematopoiesis and bone marrow fibrosis which went on and named ‘osteosclerotic anemia’. Later on, it was referred to as ‘Heuck–Assmann syndrome’. | ||
*In 1914, Hans Hirschfeld, a German hematologist further elaborated the splenic pathology in primary myelofibrosis (PMF). | |||
*The concept of [[myeloproliferative disorder]]s (MPDs) was described by William Dameshek, in 1951, by bringing together these five clinicopathologic entities: [[chronic myelogenous leukemia]] (CML), [[polycythemia vera]] (PV), [[essential thrombocythemia]] (ET), primary myelofibrosis (PMF), and [[erythroleukemia]].<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | *The concept of [[myeloproliferative disorder]]s (MPDs) was described by William Dameshek, in 1951, by bringing together these five clinicopathologic entities: [[chronic myelogenous leukemia]] (CML), [[polycythemia vera]] (PV), [[essential thrombocythemia]] (ET), primary myelofibrosis (PMF), and [[erythroleukemia]].<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | ||
*The World Health Organization utilizes the name "chronic idiopathic myelofibrosis", while the International Working Group on Myelofibrosis Research and Treatment calls the disease "primary myelofibrosis".<ref name=historyofmyelofibrosiswiki1>History of myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016</ref> | *The World Health Organization utilizes the name "chronic idiopathic myelofibrosis", while the International Working Group on Myelofibrosis Research and Treatment calls the disease "primary myelofibrosis".<ref name=historyofmyelofibrosiswiki1>History of myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016</ref> | ||
Revision as of 17:28, 8 November 2018
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis historical perspective |
|
Risk calculators and risk factors for Myelofibrosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2], Sujit Routray, M.D. [3]
Overview
The first description of primary myelofibrosis (PMF) is credited to a German surgeon, Gustav Heuck, who described the concept in 1879. Additional work and discoveries started to get documented at the beginning of the twentieth century. The substantial contribution came from Max Askanazy, a German pathologist and Herbert Assmann, an Internist from Germany. The condition was given several pseudonyms before the International Working Group for Myelofibrosis Research and Treatment decided in 2006 to use the term primary myelofibrosis (PMF).
Historical Perspective
- Gustav Heuck, a German surgeon, was the first to describe the notion of myelofibrosis in 1879. He explained the idea under the title of 'Two cases of leukemia with peculiar blood and bone marrow findings'. Heuck described two patients with massive splenomegaly, increased number of morphologically abnormal leukocytes, and nucleated red blood cells. He observed that the clinical findings in these two patients were different from those described for chronic myelogenous leukemia (CML) because of the presence of marrow fibrosis and extensive extramedullary hematopoiesis (EMH). He also noted osteosclerosis in an autopsy report.[1]
- In 1904, Max Askanazy, a German pathologist, reported a case with significant extramedullary hematopoiesis of the liver and diffuse bone marrow fibrosis.[2]
- In 1907, Herbert Assmann, an internist from Germany, described another case of extramedullary hematopoiesis and bone marrow fibrosis which went on and named ‘osteosclerotic anemia’. Later on, it was referred to as ‘Heuck–Assmann syndrome’.
- In 1914, Hans Hirschfeld, a German hematologist further elaborated the splenic pathology in primary myelofibrosis (PMF).
- The concept of myeloproliferative disorders (MPDs) was described by William Dameshek, in 1951, by bringing together these five clinicopathologic entities: chronic myelogenous leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF), and erythroleukemia.[2]
- The World Health Organization utilizes the name "chronic idiopathic myelofibrosis", while the International Working Group on Myelofibrosis Research and Treatment calls the disease "primary myelofibrosis".[3]
References
- ↑ Ansell, Stephen (2008). Rare hematological malignancies. New York, NY London: Springer. ISBN 9780387737430.
- ↑ 2.0 2.1 Tefferi, A (2007). "The history of myeloproliferative disorders: before and after Dameshek". Leukemia. 22 (1): 3–13. doi:10.1038/sj.leu.2404946. ISSN 0887-6924.
- ↑ History of myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016